Prognostic analysis of DLBCL patients and the role of upfront ASCT in high-intermediate and high-risk patients.

Oncotarget · 2017 · PMC5641203 · PMID 29069860

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP=0.084so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

Patients who received ASCT after R-CHOP showed a trend of superior PFS, but it did not reach statistical significance (P=0.084).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.